Business Challenge: AstraZeneca called on KPI Agency to increase enrollment into a flagship trial for an EGFR inhibitor in their oncology portfolio.
Solution: KPI Agency created a digital media program, developed patient-friendly messaging, launched a study website, and implemented a holistic analytics solution enrolling patients, setting new benchmarks for Oncology marketing within the organization, and optimizing the program along the way.
Result: The study met its enrollment targets ahead of schedule and led to the accelerated approval of one of AstraZeneca’s most important new cancer treatments.